BioCardia (BCDA) Income from Discontinued Operations (2010 - 2012)
BioCardia's (BCDA) quarterly Income from Discontinued Operations came in at $104000.0 in Q4 2012, up 2500.0% year-over-year from $4000.0 in Q1 2012, and down 80.45% quarter-over-quarter from $532000.0 in Q3 2012.
Analysis
BioCardia (BCDA) Income from Discontinued Operations (2010 - 2012) Analysis & Trends
BioCardia (BCDA) has reported Income from Discontinued Operations for 3 consecutive years, with $104000.0 the latest figure, recorded in Q4 2012.
- On a quarterly basis, Income from Discontinued Operations rose 2500.0% year-over-year to $104000.0 in Q4 2012; TTM through Dec 2012 was $636000.0, a 94.54% decrease from a year earlier, with the FY2012 full-year figure at $636000.0, down 94.63% from the prior year.
- Income from Discontinued Operations was $104000.0 for Q4 2012 at BioCardia, down from $532000.0 in the prior quarter.
- Over five years, Income from Discontinued Operations peaked at $12.3 million in Q2 2011 and troughed at -$8.0 million in Q3 2010.
- A 3-year average of $494625.0 and a median of -$96000.0 in 2011 frame the typical range for Income from Discontinued Operations.
- Across the five-year window, Income from Discontinued Operations soared 94.95% in 2011 and surged 2500.0% in 2012, its largest moves.
- Over 3 years, Income from Discontinued Operations stood at -$330000.0 in 2010, then jumped by 101.21% to $4000.0 in 2011, then surged by 2500.0% to $104000.0 in 2012.
- The last three Income from Discontinued Operations figures came in at $104000.0 (Q4 2012), $532000.0 (Q3 2012), and $4000.0 (Q4 2011), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | - |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | - |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 104,000.00 |
| Sep 30, 2012 | 532,000.00 |
| Dec 31, 2011 | 4,000.00 |
| Sep 30, 2011 | -404,000.00 |
| Jun 30, 2011 | 12.25 Mn |
| Mar 31, 2011 | -196,000.00 |
| Dec 31, 2010 | -330,000.00 |
| Sep 30, 2010 | -8.01 Mn |